Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 481, pseudogene (abbreviated as RN7SL481P), is a **pseudogene**—a nonfunctional segment of DNA that resembles functional genes but does not produce a functional product[1][2]. It is derived from the 7SL RNA gene, which normally encodes the RNA component of the signal recognition particle (SRP) complex involved in protein targeting to the endoplasmic reticulum[3][6][7]. However, most related sequences in the genome, including RN7SL481P, are pseudogenes formed by reverse transcription and integration of processed RNA rather than being functionally transcribed and translated[1][6][7]. These pseudogenes typically have truncated sequences and lack regulatory elements necessary for function, and they are not known to play a direct biological role or be associated with disease or drug targeting[1][2][6][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 481, pseudogene (RN7SL481P).